With multiple attempts, we over-express SOX2 (initially as SOX2-GFP construct, and later as SOX2 construct alone) in the previously SOX2 knock down CRC cells, and showed that we achieved SOX2 overexpression in the SOX2 knock down cells comparing to mock control (Data not show). The gene discussed is SOX2; the disease is colorectal carcinoma.